Chemotherapy and neoadjuvant chemotherapy are given more often to non-Hispanic black, Hispanic, and Asian women than to non-Hispanic white women with breast cancer, while black women saw a lower rate...
ORLANDO – Heart disease in women is not a top-level concern for most primary care physicians or cardiologists, according to a national survey.
Less than two in five (39%) of the surveyed primary...
Research must be increased and improved in five key areas of women’s health before any kind of recommendations for screening can be made, according to the U.S. Preventive Service Task Force’s <a...
SAN FRANCISCO – Denosumab was superior to zoledronic acid (ZA) in building bone at the lumber spine, total hip, and femoral neck in postmenopausal women with osteoporosis previously treated with oral...
CHICAGO – Contralateral prophylactic mastectomy is more expensive and provides a lower quality of life than unilateral mastectomy in younger women with sporadic breast cancer, a cost-effectiveness...
ORLANDO – Women’s awareness of the health risk posed by heart disease has stalled, with fully 45% of participants in a nationally representative survey being unaware that heart disease is the...
Human papillomavirus vaccines do not increase risk of complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS) in young women, according to a review by the European...
Physicians who treat premenopausal women with hypoactive sexual desire disorder now have a Food and Drug Administration–approved option in flibanserin. But the centrally acting daily medication comes...
SAN ANTONIO – Disadvantaged Hispanic mothers in New York enrolled in a medication clinical trial remitted from depression at a faster rate when compared with a more advantaged cohort of non-Hispanic...
Treatment with the estrogen-receptor modulator raloxifene does not significantly improve cognitive function in women with Alzheimer’s disease (AD), results of a U.S. randomized, double-blind,...
